Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1769, Issue 2, 2007, Pages 124-130

  Chalabi, Nasséra ^a,b,c   Satih, Samir ^a,b,c   Delort, Laetitia ^a,b,c   Bignon, Yves Jean ^a,b,c,d   Bernard Gallon, Dominique J ^a,b,c  

^a CENTRE JEAN PERRIN   (France)

^b INSERM   (France)

^c CRNH AUVERGNE   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Breast cancer; Hybridization; Lycopene; Profiling

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; RNA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL COMMUNICATION; CELL CYCLE; CELL STRAIN MCF 7; CONTROLLED STUDY; FATTY ACID SYNTHESIS; FIBROCYSTIC BREAST DISEASE; GAP JUNCTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA HYBRIDIZATION; XENOBIOTIC METABOLISM;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CAROTENOIDS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, COMPLEMENTARY;

LYCOPERSICON ESCULENTUM;

EID: 33847399068     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2007.01.007     Document Type: Article

References (59)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994) 66-71
2. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., and Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
3. Bieche I., Nogues C., and Lidereau R. Overexpression of BRCA2 gene in sporadic breast tumours. Oncogene 18 (1999) 5232-5238
4. Bieche I., and Lidereau R. Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue. Cancer Res. 59 (1999) 2546-2550
5. Stahl W., and Sies H. Carotenoids and protection against solar UV radiation. Skin Pharmacol. Appl. Skin Physiol. 15 (2002) 291-296
6. Levy J., Bosin E., Feldman B., Giat Y., Miinster A., Danilenko M., and Sharoni Y. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr. Cancer 24 (1995) 257-266
7. Chalabi N., Delort L., Le Corre L., Satih S., Bignon Y.J., and Bernard-Gallon D. Gene signature of breast cancer cell lines treated with lycopene. Pharmacogenomics 7 (2006) 663-672
8. Soule H.D., Vazguez J., Long A., Albert S., and Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51 (1973) 1409-1416
9. Cailleau R., Mackay B., Young R.K., and Reeves Jr. W.J. Tissue culture studies on pleural effusions from breast carcinoma patients. Cancer Res. 34 (1974) 801-809
10. Soule H.D., Maloney T.M., Wolman S.R., Peterson Jr. W.D., Brenz R., McGrath C.M., Russo J., Pauley R.J., Jones R.F., and Brooks S.C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50 (1990) 6075-6086
11. Chalabi N., Le Corre L., Maurizis J.C., Bignon Y.J., and Bernard-Gallon D.J. The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression. Eur. J. Cancer 40 (2004) 1768-1775
12. Le Brigand K., Russell R., Moreilhon C., Rouillard J.M., Jost B., Amiot F., Magnone V., Bole-Feysot C., Rostagno P., Virolle V., Defamie V., Dessen P., Williams G., Lyons P., Rios G., Mari B., Gulari E., Kastner P., Gidrol X., Freeman T.C., and Barbry P. An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Res. 34 (2006) e87
13. Wettenhall J.M., and Smyth G.K. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20 (2004) 3705-3706
14. Edwards D. Non-linear normalization and background correction in one-channel cDNA microarray studies. Bioinformatics 19 (2003) 825-833
15. Hosack D.A., Dennis Jr. G., Sherman B.T., Lane H.C., and Lempicki R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4 (2003) R70
16. James W.P. Food agencies and food standards: the future regulatory mechanism for the food trade?. Nutrition 16 (2000) 631-633
17. Cousins R.J. Nutritional regulation of gene expression. Am. J. Med. 106 (1999) 20S-23S (discussion 50S-51S)
18. Hesketh J.E., Vasconcelos M.H., and Bermano G. Regulatory signals in messenger RNA: determinants of nutrient-gene interaction and metabolic compartmentation. Br. J. Nutr. 80 (1998) 307-321
19. Salati L.M., Szeszel-Fedorowicz W., Tao H., Gibson M.A., Amir-Ahmady B., Stabile L.P., and Hodge D.L. Nutritional regulation of mRNA processing. J. Nutr. 134 (2004) 2437S-2443S
20. Bhuvaneswari V., and Nagini S. Lycopene: a review of its potential as an anticancer agent. Curr. Med. Chem. Anticancer Agents 5 (2005) 627-635
21. Ando S., De Amicis F., Rago V., Carpino A., Maggiolini M., Panno M.L., and Lanzino M. Breast cancer: from estrogen to androgen receptor. Mol. Cell. Endocrinol. 193 (2002) 121-128
22. Fan S., Wang J., Yuan R., Ma Y., Meng Q., Erdos M.R., Pestell R.G., Yuan F., Auborn K.J., Goldberg I.D., and Rosen E.M. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284 (1999) 1354-1356
23. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 3 (2000) 561-576
24. Hajduch E., Litherland G.J., and Hundal H.S. Protein kinase B (PKB/Akt)-A key regulator of glucose transport?. FEBS Lett. 492 (2001) 199-203
25. Fry M.J. Phosphoinositide 3-kinase signalling in breast cancer: how big a role might it play?. Breast Cancer Res. 3 (2001) 304-312
26. Viglietto G., Motti M.L., Bruni P., Melillo R.M., D'Alessio A., Califano D., Vinci F., Chiappetta G., Tsichlis P., Bellacosa A., Fusco A., and Santoro M. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8 (2002) 1136-1144
27. Shin I., Yakes F.M., Rojo F., Shin N.Y., Bakin A.V., Baselga J., and Arteaga C.L. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 8 (2002) 1145-1152
28. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
29. Gutzman J.H., Nikolai S.E., Rugowski D.E., Watters J.J., and Schuler L.A. Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos. Mol. Endocrinol. 19 (2005) 1765-1778
30. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., and Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74 (2000) 311-317
31. Harbour J.W., Luo R.X., Dei Santi A., Postigo A.A., and Dean D.C. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98 (1999) 859-869
32. Keyomarsi K., Tucker S.L., Buchholz T.A., Callister M., Ding Y., Hortobagyi G.N., Bedrosian I., Knickerbocker C., Toyofuku W., Lowe M., Herliczek T.W., and Bacus S.S. Cyclin E and survival in patients with breast cancer. N. Engl. J. Med. 347 (2002) 1566-1575
33. Lewis D.F. 57 varieties: the human cytochromes P450. Pharmacogenomics 5 (2004) 305-318
34. Nebert D.W., and Vasiliou V. Analysis of the glutathione S-transferase (GST) gene family. Hum. Genomics 1 (2004) 460-464
35. Le March L., Franke A.A., Custer L., Wilkens L.R., and Cooney R.V. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics 7 (1997) 11-19
36. Dhakshinamoorthy S., Long II D.J., and Jaiswal A.K. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr. Top. Cell Regul. 36 (2000) 201-216
37. Chen H., Howald W.N., and Juchau M.R. Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab. Dispos. 28 (2000) 315-322
38. Du L., Hoffman S.M., and Keeney D.S. Epidermal CYP2 family cytochromes P450. Toxicol. Appl. Pharmacol. 195 (2004) 278-287
39. White J.A., Beckett-Jones B., Guo Y.D., Dilworth F.J., Bonasoro J., Jones G., and Petkovich M. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J. Biol. Chem. 272 (1997) 18538-18541
40. Wakil S.J. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28 (1989) 4523-4530
41. Ye Q., Chung L.W., Li S., and Zhau H.E. Identification of a novel FAS/ER-alpha fusion transcript expressed in human cancer cells. Biochim. Biophys. Acta 1493 (2000) 373-377
42. Menendez J.A., Vellon L., Mehmi I., Oza B.P., Ropero S., Colomer R., and Lupu R. Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10715-10720
43. Fuhrman B., Elis A., and Aviram M. Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem. Biophys. Res. Commun. 233 (1997) 658-662
44. Elson C.E., Peffley D.M., Hentosh P., and Mo H. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer. Proc. Soc. Exp. Biol. Med. 221 (1999) 294-311
45. Zhang L.X., Cooney R.V., and Bertram J.S. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 12 (1991) 2109-2114
46. Zhang L.X., Cooney R.V., and Bertram J.S. Carotenoids up-regulate connexin43 gene expression independent of their provitamin A or antioxidant properties. Cancer Res. 52 (1992) 5707-5712
47. Hotz-Wagenblatt A., and Shalloway D. Gap junctional communication and neoplastic transformation. Crit. Rev. Oncog. 4 (1993) 541-558
48. Stahl W., von Laar J., Martin H.D., Emmerich T., and Sies H. Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch. Biochem. Biophys. 373 (2000) 271-274
49. Stahl W., Nicolai S., Briviba K., Hanusch M., Broszeit G., Peters M., Martin H.D., and Sies H. Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching. Carcinogenesis 18 (1997) 89-92
50. Bertram J.S. Carotenoids and gene regulation. Nutr. Rev. 57 (1999) 182-191
51. Loewenstein W.R. Junctional intercellular communication: the cell-to-cell membrane channel. Physiol. Rev. 61 (1981) 829-913
52. Mehta P.P., Lokeshwar B.L., Schiller P.C., Bendix M.V., Ostenson R.C., Howard G.A., and Roos B.A. Gap-junctional communication in normal and neoplastic prostate epithelial cells and its regulation by cAMP. Mol. Carcinog. 15 (1996) 18-32
53. Mehta P.P., Bertram J.S., and Loewenstein W.R. Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44 (1986) 187-196
54. Nicolson G.L., Lichtner R.B., and Trosko J.E. Cytoskeletal and junctional heterogeneity in mammary tumor cells and their possible significance in tumor progression. Adv. Exp. Med. Biol. 233 (1988) 21-26
55. Zhu D., Caveney S., Kidder G.M., and Naus C.C. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 1883-1887
56. Naus C.C., Elisevich K., Zhu D., Belliveau D.J., and Del Maestro R.F. In vivo growth of C6 glioma cells transfected with connexin43 cDNA. Cancer Res. 52 (1992) 4208-4213
57. Mor-Vaknin N., Punturieri A., Sitwala K., and Markovitz D.M. Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5 (2003) 59-63
58. Boosalis M.G., Snowdon D.A., Tully C.L., and Gross M.D. Acute phase response and plasma carotenoid concentrations in older women: findings from the nun study. Nutrition 12 (1996) 475-478
59. Porrini M., and Riso P. Lymphocyte lycopene concentration and DNA protection from oxidative damage is increased in women after a short period of tomato consumption. J. Nutr. 130 (2000) 189-192